您的位置:山东大学 -> 科技期刊社 -> 《山东大学学报(医学版)》

山东大学学报(医学版) ›› 2016, Vol. 54 ›› Issue (5): 17-22.doi: 10.6040/j.issn.1671-7554.0.2015.688

• • 上一篇    下一篇

EGCG对老龄大鼠阴茎组织中PRMT1、DDAH、ADMA、NOS通路的影响

陈东1,马专昌2,李博1,孙鼎琪1,张克勤1,张辉1,傅强1   

  1. 1.山东大学附属省立医院泌尿外科, 山东 济南 250021;2.威海卫人民医院泌尿外科, 山东 威海 264200
  • 收稿日期:2015-07-21 出版日期:2016-05-16 发布日期:2016-05-16
  • 通讯作者: 傅强. E-mail:qiangfu68@163.com E-mail:qiangfu68@163.com

Effects of EGCG on PRMT1, DDAH, ADMA and NOS pathway in corpus cavernosum of aged rats

CHEN Dong1, MA Zhuanchang2, LI Bo1, SUN Dingqi1, ZHANG Keqin1, ZHANG Hui1, FU Qiang1   

  1. 1. Department of Urology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan 250021, Shandong, China;
    2. Department of Urology, Weihaiwei Peoples Hospital, Weihai 264200, Shandong, China
  • Received:2015-07-21 Online:2016-05-16 Published:2016-05-16

摘要: 目的 研究表没食子儿茶素没食子酸酯( EGCG)对老龄大鼠阴茎组织中蛋白质精氨酸甲基转移酶1(PRMT1)、二甲基精氨酸二甲胺水解酶(DDAH)、不对称二甲基精氨酸(ADMA)、一氧化氮合酶(NOS)通路表达的影响,探讨其对改善老龄大鼠勃起功能效果。 方法 3月龄雄性SD大鼠10只(青年组),18月龄雄性SD大鼠40只,其中筛选出老龄勃起功能障碍(ED)大鼠30只,随机分为老龄组,小剂量治疗组(10 mg/kg EGCG)和大剂量治疗组(100 mg/kg EGCG),每组各10只。连续EGCG灌胃治疗12 周后,测定最大海绵体内压(Max ICP)、平均动脉压(MAP)和Max ICP/ MAP,处死各组大鼠取阴茎组织。应用免疫组化和Western blotting 法测定大鼠阴茎组织中PRMT1、DDAH和NOS表达。酶联免疫法检测大鼠阴茎组织中ADMA和环磷鸟苷(cGMP)含量。黄嘌呤氧化法测定大鼠阴茎海绵体中超氧化物歧化酶(SOD)活性,硫代巴比妥酸法检测丙二醛(MDA)含量。 结果 与青年组比较,老龄组Max ICP/MAP降低(P<0.05),SOD活性下降(P<0.05),MDA 含量增高(P<0.05),cGMP含量降低(P<0.05),ADMA含量升高(P<0.05),DDAH和NOS蛋白表达量均降低(P<0.05),PRMT1蛋白表达量升高(P<0.05)。与老龄组比较,大、小剂量组治疗可使老龄大鼠Max ICP/MAP升高(P<0.05),SOD活性升高(P<0.05),MDA含量降低(P<0.05),cGMP含量升高(P<0.05),ADMA含量降低(P<0.05),DDAH和NOS蛋白表达量明显升高(P<0.05),PRMT1蛋白表达量降低(P<0.05)。 结论 EGCG可以通过其抗氧化作用, 在一定程度上调节PRMT1、DDAH、ADMA、NOS通路在老龄大鼠阴茎组织中的表达,改善老龄大鼠勃起功能。

关键词: 不对称二甲基精氨酸, 二甲基精氨酸二甲胺水解酶, 表没食子儿茶素没食子酸酯, 蛋白质精氨酸甲基转移酶1, 勃起功能障碍

Abstract: Objective To elucidate the effects of epigallocatechin-3-gallate(EGCG)on protein arginine methyltransferase 1(PRMT1), dimethylarginine dimethylaminohydrolases(DDAH), asymmetrical dimethylarginine(ADMA), and nitric oxide synthase(NOS)pathway in corpus cavernosum of aged rats, and to investigate the possible mechanisms. Methods A total of 30(erectile dysfunction)ED rats were screened among 40 18-month-old male SD rats, and randomly divided into the aged group(n=10), small dose group(daily gavage feedings of EGCG at doses of 10 mg/kg for 12 weeks, n=10)and large dose group(daily gavage feedings of EGCG at doses of 100 mg/kg for 12 weeks, n=10). Another 10 3-month-old rats served as controls. After 12 weeks, the maximal intracavernous pressure(Max ICP), mean arterial blood pressure(MAP)and Max ICP/MAP were determined. The animals were then sacri- 山 东 大 学 学 报 (医 学 版)54卷5期 -陈东,等.EGCG对老龄大鼠阴茎组织中PRMT1、DDAH、ADMA、NOS通路的影响 \=-ficed to harvest penis tissues. PRMT1, DDAH and NOS levels were detected with Western blotting and immunohistochemistry. ADMA and cGMP levels were assessed with ELISA. The MDA level and SOD activity were also detected. Results Compared with the control group, the aged group had decreased Max ICP/MAP, DDAH, NOS, cGMP and SOD activity(all P<0.05). Compared with the aged group, small and large dose group had significantly increased Max ICP/MAP, SOD activity, cGMP, DDAH and NOS levels, but decreased MDA, ADMA, and PRMT1(all P<0.05). Conclusion EGCG treatment could ameliorate erectile function in aged rats via upregulating PRMT1, DDAH, ADMA and NOS pathway and inhibiting oxidative stress.

Key words: Asymmetrical dimethylarginine, Dimethylarginine dimethylaminohydrolases, Epigallocatechin-3-gallate, Erectile dysfunction, Protein arginine methyltransferase 1

中图分类号: 

  • R698.1
[1] McVary KT. Clinical practice. Erectile dysfunction[J]. N Engl J Med, 2007, 357(24):2472-2481.
[2] Mola JR. Erectile dysfunction in the older adult male[J]. Urol Nurs, 2015, 35(2):87-93.
[3] Kim HS, Quon MJ, Kim JA. New insights into the mechanisms of polyphenols beyond antioxidant properties; lessons from the green tea polyphenol, epigallocatechin 3-gallate[J]. Redox Biol, 2014, 2:187-195. doi:10.1016/j.redox.2013.12.022.eCollection 2014.
[4] Chen D, Milacic V, Chen MS, et al. Tea polyphenols, their biological effects and potential molecular targets[J]. Histol Histopathol, 2008, 23(4):487-496.
[5] Grassi D, Desideri G, Di Giosia P, et al. Tea, flavonoids, and cardiovascular health: endothelial protection[J]. Am J Clin Nutr, 2013, 98(6 Suppl):1660S-1666S.
[6] Wang SJ, Zhao SJ, Wang YS, et al. Effects of estrogen intervention on the biomechanical characteristics of serum SOD, MDA, and middle cerebral artery in aged female rats[J]. Clin Exp Obstet Gynecol, 2015, 42(3):295-299.
[7] Forstermann U. Nitric oxide and oxidative stress in vascular disease[J]. Pflugers Arch, 2010, 459(6):923-939.
[8] Mostafa T, Sabry D, Abdelaal AM, et al. Cavernous antioxidant effect of green tea, epigallocatechin-3-gallate with/without sildenafil citrate intake in aged diabetic rats[J]. Andrologia, 2013, 45(4):272-277.
[9] Silva CN, Nunes KP, Torres FS, et al. PnPP-19, a synthetic and nontoxic peptide designed from a phoneutria nigriventer toxin, potentiates erectile function via NO/cGMP[J]. J Urol, 2015. pii:S0022-5347(15)04292-5. doi:10.1016/j.juro.2015.06.081. [Epub ahead of print]
[10] Matsui H, Sopko NA, Hannan JL, et al. Pathophysiology of erectile dysfunction[J]. Curr Drug Targets, 2015, 16(5):411-419.
[11] Wang JH, Chen D, Zhang KQ, et al. Effect of DDAH/ADMA/NOS regulation pathway on cavernae corporum cavernosorum rat penis of different age[J]. Andrologia, 2015. doi:10.1111/and.12441. [Epub ahead of print]
[12] Konya H, Miuchi M, Satani K, et al. Asymmetric dimethylarginine, a biomarker of cardiovascular complications in diabetes mellitus[J]. World J Exp Med, 2015, 5(2):110-119.
[13] Palm F, Onozato ML, Luo Z, et al. Dimethylarginine dimethylaminohydrolase(DDAH): expression, regulation, and function in the cardiovascular and renal systems[J]. Am J Physiol Heart Circ Physiol, 2007, 293(6):H3227-3245.
[14] Antoniades C, Shirodaria C, Leeson P, et al. Association of plasma asymmetrical dimethylarginine(ADMA)with elevated vascular superoxide production and endothelial nitric oxide synthase uncoupling: implications for endothelial function in human atherosclerosis[J]. Eur Heart J, 2009, 30(9):1142-1150.
[1] 尹延彦,赵林远,张晓欢,黄辉,孙贝贝,李文杰. EGCG对铅暴露C57BL/6仔鼠海马Aβ蛋白及NEP酶表达的影响[J]. 山东大学学报(医学版), 2016, 54(12): 8-13.
[2] 赵蕙琛,柴家超,张亮,袁明振,彭力,刘元涛. 糖尿病大鼠阴茎海绵体硫化氢含量及其合成酶表达的变化[J]. 山东大学学报(医学版), 2016, 54(10): 25-28.
[3] 辛玉1,袁俊华2,孙成刚1. EGCG抑制结肠癌HT-29细胞生长及血管生成的作用机制[J]. 山东大学学报(医学版), 2013, 51(3): 21-26.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!